Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline / 中华流行病学杂志
Chinese Journal of Epidemiology
;
(12): 747-754, 2022.
Article
Dans Chinois
| WPRIM
| ID: wpr-935454
ABSTRACT
Pharmacogenetic studies are designed to investigate the associations between genetic variation and treatment response for a particular drug in terms of both efficacy and adverse events and have high sample size requirements. To improve the quality of pharmacogenetic studies and facilitate the Meta-analyses to investigate statistically significant associations, Strengthening the Reporting of Pharmacogenetic Studies (STROPS) guideline was developed in 2020 based on the Strengthening the Reporting of Genetic Association Studies (STREGA) statement. The objective of this article is to present a brief introduction to the STROPS guideline and an interpretation of the key points in some items with examples for the better understanding and application.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Études d'associations génétiques
/
Rapport de recherche
/
Test pharmacogénomique
Type d'étude:
Guide de pratique
/
Revues systématiques évaluées
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Epidemiology
Année:
2022
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS